Thymomas express epitopes shared by the ryanodine receptor

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Myasthenia gravis (MG) is an autoimmune disorder often associated with thymoma.
• Patients with thymoma and MG frequently exhibit antibodies against the ryanodine receptor (RyR).
• The specific role of RyR in thymoma-associated MG remains under investigation.

Purpose of the Study:

• To investigate the expression of ryanodine receptor (RyR) epitopes in thymoma tissue.
• To determine if thymoma epithelial cells express RyR-related antigens recognized by patient antibodies.
• To identify specific RyR regions involved in the autoimmune response in thymoma-associated myasthenia gravis.

Main Methods:

• Thymoma tissue samples were analyzed using a panel of polyclonal rabbit antibodies against various RyR peptides.
• Immunohistochemistry was performed on cryosections of thymoma using anti-RyR peptide antibodies.
• Western blotting was employed to detect RyR-related peptides in thymoma membrane fractions.

Main Results:

• An antibody targeting peptide C2, located in the RyR transmembrane region, stained epithelial cells in 17 out of 23 thymoma samples.
• This anti-C2 RyR antibody detected a 40-kDa peptide in thymoma membrane fractions via Western blot.
• No reactivity was observed with normal thymus, tonsil, or colon carcinoma tissues, indicating specificity for thymoma.

Conclusions:

• Epithelial cells of thymoma express a specific epitope shared with the transmembrane region of skeletal and cardiac muscle RyR.
• This finding suggests that RyR transmembrane epitopes are involved in the pathogenesis of thymoma-associated myasthenia gravis.
• The anti-C2 RyR antibody serves as a valuable tool for identifying this specific RyR epitope in thymoma.